ARX
Aroa Biosurgery Ltd
Biotechnology
·
Healthcare
11
comments
3
fund managers
past 90 days
About Aroa Biosurgery Ltd
Aroa Biosurgery Ltd., founded in 2008 and based in Mangere, New Zealand, develops, manufactures, and markets soft tissue repair products. The company specializes in advanced healing solutions for complex wounds and soft tissue reconstruction. Its product applications include abdominal wall repair, breast reconstruction, and surgical procedures for trauma, tumor resections, and limb salvage. By focusing on regenerative medicine, Aroa Biosurgery provides clinical solutions for complex surgical and soft tissue repair needs.
Commentary Volume
11
Comments
3
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$208M
Fund managers
3 managers
First covered
30 Sept 2024
Last updated
31 Mar 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Aroa Biosurgery Ltd (ASX:ARX)
Frequently asked questions
Who is investing in Aroa Biosurgery Ltd (ASX:ARX)?
Fund managers including Forager Funds, Jencay Capital and Acorn Capital have invested in Aroa Biosurgery Ltd (ASX:ARX).
What is the short interest in Aroa Biosurgery Ltd (ASX:ARX)?
The short interest in Aroa Biosurgery Ltd (ASX:ARX) is 0.17% which makes it the 365th most shorted stock on the ASX. Of the 345.0M shares that Aroa Biosurgery Ltd has on issue, 594.5K have been sold short.
What does Aroa Biosurgery Ltd (ASX:ARX) do?
Aroa Biosurgery Ltd., founded in 2008 and based in Mangere, New Zealand, develops, manufactures, and markets soft tissue repair products. The company specializes in advanced healing solutions for complex wounds and soft tissue reconstruction. Its product applications include abdominal wall repair, breast reconstruction, and surgical procedures for trauma, tumor resections, and limb salvage. By focusing on regenerative medicine, Aroa Biosurgery provides clinical solutions for complex surgical and soft tissue repair needs.
Loading...